Information Provided By:
Fly News Breaks for January 31, 2018
NWSA, BX, TRI, FDS
Jan 31, 2018 | 06:14 EDT
DA Davidson analyst Peter Heckmann says that yesterday's disclosure of advanced talks between Blackstone (BX) and Thomson Reuters (TRI) about the sale of the latter's Financial & Risk - F&R - operations is a negative for Factset (FDS). The analyst believes that most of the market share wins for Factset have come from Reuters over the past two decades, and Blackstone's ability to better focus investments in the financial data business may make competitive wins for difficult. Heckmann keeps his Neutral rating and $174 price target, adding "FactSet's shares will be challenged to outperform the peer group over the next year".
News For FDS;TRI;BX;NWSA From the Last 2 Days
BX
Mar 27, 2024 | 06:37 EDT
Blackstone (BX) announced a new collaboration with Moderna (MRNA) through a development and commercialization funding agreement where funds managed by Blackstone Life Sciences will provide up to $750M to fund Moderna's influenza program. This new collaboration continues Blackstone Life Sciences' work and support for many of the world's leading and most innovative biopharmaceutical and medical technology companies. Blackstone seeks to provide customized financing solutions for companies across therapeutic areas to support mission critical scientific innovation and advance important products to patients.